✦ LIBER ✦

Late onset pyridoxine-responsive sideroblastic anaemia after allogeneic bone marrow transplantation

✍ Scribed by M. D. Nicholls; K. Atkinson; Dr J. C. Biggs; A. J. Concannon; A. J. Dodds

Book ID: 114710140
Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 273 KB
Volume: 56
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1984.tb01281.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late-onset cerebral toxoplasmosis after

Late-onset cerebral toxoplasmosis after allogeneic bone marrow transplantation

✍ Tefferi, A; O’Neill, B P; Inwards, D J 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

Late onset haemolysis and red cell autoi

Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant

✍ Chen, F E; Owen, I; Savage, D; Roberts, I; Apperley, J; Goldman, J M; Laffan, M 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 57 KB

Late-onset herpes simplex virus-associat

Late-onset herpes simplex virus-associated interstitial pneumonia after allogeneic bone marrow transplantation

✍ Kitabayashi, A; Hirokawa, M; Horiuchi, T; Kawabata, Y; Miura, A B 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

Late outcomes after bone marrow transpla

Late outcomes after bone marrow transplant for aplastic anaemia

✍ Mary Eapen; Norma K. C. Ramsay; Ann C. Mertens; Leslie L. Robison; Todd DeFor; S 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Long-term survival and late death after

Long-term survival and late death after allogeneic bone marrow transplantation

📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 38 KB

Very late relapse of chronic myelogenous

Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation

✍ Arunabh Sekhri; Delong Liu; Muhammad Rasul; Nasir Ahmed; Tauseef Ahmed; Karen Se 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Allogeneic stem cell transplantation is considered to be a curative treatment modality in patients with chronic myelogenous leukemia. However patients are at risk for relapse years after transplantation. Currently we present two patients who relapsed 16 and 24 years after allogeneic bone marrow tran